An annual survey from the Reputation Institute has found that, contrary to the belief of many in the industry, pharma’s reputation is “strong” – an improvement on the previous three years’ “average/moderate” score (1). The study asked participants about a number of factors, including whether or not companies have a “positive influence on society” or “behave ethically.” The survey found that 11 of the 17 companies analyzed had improved their reputation over the past year, with only two companies losing reputation. Here, we delve a little deeper into some of the figures from the report.

References
- Reputation Institute, Pharma RepTrak 2017, (2017). Available at: http://bit.ly/2swwEj6. Last accessed 13 June, 2017.